Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Karen A. Canella

Principal of Pearce, Bevill, Leesburg, Moore, P.C.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 Oct, 2022
artem shef profile picture
artem shef
edited on 1 Oct, 2022
Infobox
Educated at
Auburn University
Auburn University
0
artem shef profile picture
artem shef
edited on 1 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Educated at
Auburn University
Auburn University
artem shef profile picture
artem shef
edited on 1 Oct, 2022
Infobox
Location
Birmingham, Alabama
Birmingham, Alabama
0
artem shef profile picture
artem shef
edited on 1 Oct, 2022
artem shef profile picture
artem shef
edited on 1 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Location
Birmingham, Alabama
Birmingham, Alabama
artem shef profile picture
artem shef
edited on 1 Oct, 2022
Edits made to:
Description (+50 characters)
‌

Karen A. Canella

Principal of Pearce, Bevill, Leesburg, Moore, P.C.

Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-238 properties)
Infobox
Patent primary examiner of
‌
US Patent 7094750 Therapeutic pore-forming peptides
‌
US Patent 7098311 Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
‌
US Patent 7101674 Anti-idiotypic anti-TNF antibodies and related immunoassay methods
‌
US Patent 7101967 Transport vectors
‌
US Patent 7105149 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/myeloma
‌
US Patent 7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
‌
US Patent 7109159 Leptin as an inhibitor of tumor cell proliferation
‌
US Patent 7112403 Method for the identification of anesthetics
‌
US Patent 7112420 Lymphoma associated molecules and uses therefor
‌
US Patent 7115710 Diagnosis and treatment of PTP related disorders
‌
US Patent 7118853 Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors
‌
US Patent 7122182 Oncolytic virus therapy
‌
US Patent 7122343 Methods to alter levels of a DNA repair protein
‌
US Patent 7122517 Crystallized structure of type IV collagen NC1 domain hexamer
‌
US Patent 7125658 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
‌
US Patent 7128922 Compositions of leukaemia inhibitory factor
‌
US Patent 7129039 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
‌
US Patent 7129040 Tumor suppressor designated TS10q23.3
‌
US Patent 11173213 Method for selectively manufacturing antibody-drug conjugate
‌
US Patent 7138497 Biosynthetic binding proteins for immuno-targeting
‌
US Patent 7153660 Non-invasive enzyme screen for tissue remodelling-associated conditions
‌
US Patent 7153931 Transport vectors
‌
US Patent 7160686 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum
‌
US Patent 7160695 Molecules of the PYRIN/NBS/LRR protein family and uses thereof
‌
US Patent 7172898 103P2D6: tissue specific protein highly expressed in various cancers
‌
US Patent 7183049 Cell regulatory genes, encoded products, and uses related thereto
‌
US Patent 7183064 Method for identifying pre-neoplastic and/or neoplastic states in mammals
‌
US Patent 7189504 Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites
‌
US Patent 7192698 EphA2 as a diagnostic target for metastatic cancer
‌
US Patent 7199220 103P2D6: tissue specific protein highly expressed in various cancers
‌
US Patent 7208581 TRAF family proteins
‌
US Patent 7211433 Method for the enriching or depleting tumor cells obtained from a body fluid and kit suitable for this purpose
‌
US Patent 7217413 Use of novel agents inducing cell death in synergy with interferons
‌
US Patent 7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis
‌
US Patent 7220412 Method of preparing an undifferentiated cell
‌
US Patent 7220557 METH1 polynucleotides
‌
US Patent 7223397 Potentiation of anti-CD38-Immunotoxin cytotoxicity
‌
US Patent 7229621 Method to enhance the immunogenicity of an antigen
‌
US Patent 7238471 Method of diagnosing, monitoring, staging, imaging and treating breast cancer
‌
US Patent 7247453 Calcium binding recombinant antibody against protein C
‌
US Patent 7252973 Protein and processes for producing the same
‌
US Patent 7259022 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
‌
US Patent 7262058 Method for determining lipid associated sialoprotein in body fluids
‌
US Patent 7270960 Diagnosis of ovarian carcinomas
‌
US Patent 7282350 Labeled cell sets for use as functional controls in rare cell detection assays
‌
US Patent 7288243 Aerosol drug inhibition of lung metastases
‌
US Patent 7288249 Antibodies for cancer therapy and diagnosis
‌
US Patent 7294459 Cell regulatory genes, encoded products, and uses related thereto
‌
US Patent 7297330 Low dose haptenized tumor cell and tumor cell extract immunotherapy
‌
US Patent 7300749 Molecules of the pyrin domain protein family and uses thereof
‌
US Patent 7303740 Methods for the diagnosis and treatment of breast cancer
‌
US Patent 7303749 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
‌
US Patent 7303866 Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof
‌
US Patent 7306796 13-transmembrane protein expressed in prostate cancer
‌
US Patent 7306919 Antigen-antibody cancer recognition system
‌
US Patent 7307071 RAF-MEK-ERK pathway inhibitors to treat cancer
‌
US Patent 7309486 HER cancer protocols
‌
US Patent 7312024 Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
‌
US Patent 7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in
‌
US Patent 7314915 Fluorescent proteins
‌
US Patent 7318921 Therapeutic compositions that alter the immune response
‌
US Patent 7319006 Serpentine transmembrane antigens expressed in human cancers and uses thereof
‌
US Patent 7326402 Method of diagnosing, monitoring, staging, imaging and treating cancer
‌
US Patent 7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
‌
US Patent 7329542 Probes for identifying cancer-specific antigens
‌
US Patent 7335354 Methods for the reduction of malignant tumors by an eosinophil/helminth therapy
‌
US Patent 7335357 Antagonists of neuropilin receptor function and use thereof
‌
US Patent 7341733 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
‌
US Patent 7344714 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
‌
US Patent 7345020 Mimetics of CD4 that inhibit immune response
‌
US Patent 7351530 Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer
‌
US Patent 7354703 Securin is required for chromosomal stability in human cells
‌
US Patent 7354705 Methods for cancer prognosis and diagnosis
‌
US Patent 7354898 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
‌
US Patent 7358042 Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
‌
US Patent 7358262 Identification of genotype-selective anti-tumor agents
‌
US Patent 7361329 Compositions for inducing an immune response
‌
US Patent 7361336 Methods of cancer therapy targeted against a cancer stem line
‌
US Patent 7361340 Antibody against tumor specific antigen as target
‌
US Patent 7361346 Therapeutic compositions that produce an immune response
‌
US Patent 11180532 Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
‌
US Patent 7364868 Krüppel-like transcriptional factor KLF4/GKLF and uses thereof
‌
US Patent 7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
‌
US Patent 7378096 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
‌
US Patent 7378233 BRAF mutation T1796A in thyroid cancers
‌
US Patent 7384418 Methods and devices for delivery of agents to breast milk ducts
‌
US Patent 7387873 Human myeloma cell line
‌
US Patent 7393685 Method for cultivating cancer cells from human tissue and device for preparing tissue samples
‌
US Patent 7402307 Method for identifying and killing cancer cells
‌
US Patent 7402403 Tumour markers
‌
US Patent 7402409 Cell fusion method
‌
US Patent 7402556 Prodrugs activated by plasmin and their use in cancer chemotherapy
‌
US Patent 7410773 Method of preparing an undifferentiated cell
‌
US Patent 7410953 Anticancer agent
‌
US Patent 7413737 Anti-hydroxylase antibodies and uses thereof
‌
US Patent 7413864 Treating cancer using a telomerase vaccine
‌
US Patent 7416893 Methods for diagnosing drug-resistant cancer cells or for identifying chemotherapeutic agents by measuring anomalous intracellular ion and/or second messenger dynamics
‌
US Patent 7417124 Antibodies specific for phosphorylation sites and screening methods using the same antibodies
‌
US Patent 7419777 Method and quantification assay for determining c-kit/SCF/pAKT status
‌
US Patent 7420039 Individualized anti-cancer antibodies
‌
US Patent 7422862 Methods for identifying modulators of apoptosis
‌
US Patent 7425535 Therapeutic pore-forming peptides
‌
US Patent 7427665 Chronic lymphocytic leukemia cell line
‌
US Patent 7429448 Therapeutic use of the SMR1 protein and active derivatives thereof
‌
US Patent 7435412 Chronic lymphocytic leukemia cell line
‌
US Patent 7438890 Binding peptides for carcinoembryonic antigen (CEA)
‌
US Patent 7438922 Human prostate cell lines in cancer treatment
‌
US Patent 7442781 Diagnosis, prevention and treatment of cancer
‌
US Patent 7456146 Lytic peptide prodrugs
‌
US Patent 7459536 HGF-SF monoclonal antibody combinations
‌
US Patent 7462691 Mouse prostate stem cell antigen and uses thereof
‌
US Patent 7462704 Tumor marker and its use
‌
US Patent 7468254 Cytotoxicity mediation of cells evidencing surface expression of MCSP
‌
US Patent 7470658 Methods for inhibiting tumor metastasis, and peptides useful therefor
‌
US Patent 7476496 Method for preparing an extracellular matrix and its use for tumor cell culture
‌
US Patent 7476649 Antiproliferative and antiviral proteins and peptides
‌
US Patent 7479266 Polyvalent conjugate vaccine for cancer
‌
US Patent 7485296 PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer
‌
US Patent 7491530 Fusion partner cells and uses thereof
‌
US Patent 7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma
‌
US Patent 7498029 Photoimmunotherapies for cancer using combination therapies
‌
US Patent 7498170 Bone precursor cells: compositions and methods
‌
US Patent 7498407 Vascular endothelial cell growth inhibitor, VEGI-192a
‌
US Patent 7504256 Process for producing polypeptide
‌
US Patent 7507549 Method for following the progress of prostate cancer
‌
US Patent 7511031 Noninvasive vascular therapy
‌
US Patent 7521047 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
‌
US Patent 7521423 Exendin pharmaceutical compositions
‌
US Patent 7527786 Methods for inhibiting the growth of cancer cells expressing PSCA
‌
US Patent 7527793 Immunogenic peptides
‌
US Patent 7527933 Genetic products differentially expressed in tumors and the use thereof
‌
US Patent 7528106 Compositions and methods for treatment of neovascular diseases
‌
US Patent 7528224 Peptide for triggering an immune reaction against tumor cells
‌
US Patent 7528236 Humanized anti-beta7 antagonists and uses therefor
‌
US Patent 7531501 Method of treating endothelial injury
‌
US Patent 7534417 103P2D6: tissue specific protein highly expressed in various cancers
‌
US Patent 7541025 Treatment of malignant tumor
‌
US Patent 7541442 Antibodies and related molecules that bind to PSCA proteins
‌
US Patent 7544465 Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity
‌
US Patent 7550426 Acetylated therapeutic procytotoxins
‌
US Patent 7556796 Directed complementation
‌
US Patent 7557139 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
‌
US Patent 7557187 Purified SR-p70 protein
‌
US Patent 7560226 Assay to detect a binding partner
‌
US Patent 7560437 Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
‌
US Patent 7563446 Methods and compositions for inducing autoimmunity in the treatment of cancers
‌
US Patent 7566452 Cancer treatment with endothelin receptor antagonists
‌
US Patent 7569668 Method to control tumor progression and invasiveness
‌
US Patent 7572762 Materials and methods relating to the induction of apoptosis in target cells
‌
US Patent 7572895 Transferrin receptor antibodies
‌
US Patent 7575896 Cell fusion method
‌
US Patent 7575926 Method of identification of compounds effective against suppressed cancer cells
‌
US Patent 7595042 Oncolytic virus therapy
‌
US Patent 7595379 Antibodies and related molecules that bind to PSCA proteins
‌
US Patent 7598030 Antibodies against cancer produced using masked cancer cells as immunogen
‌
US Patent 7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
‌
US Patent 7604933 Method for sorting tumor cells
‌
US Patent 7608262 Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
‌
US Patent 7612162 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
‌
US Patent 7615358 Method for determining the concentration of vital epithelial tumor cells in a body fluid
‌
US Patent 7622261 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same
‌
US Patent 7622478 1-nitroacridine/tumor inhibitor compositions
‌
US Patent 7622549 Human telomerase reverse transcriptase polypeptides
‌
US Patent 7622564 Prostate stem cell antigen (PSCA) variants and subsequences thereof
‌
US Patent 7625567 Induction of immune responses to isoaspartyl-modified antigens
‌
US Patent 7625573 Sensitization process for antigen-presenting cells and means for implementing the process
‌
US Patent 7628975 Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolites
‌
US Patent 7632660 Lymphoma associated molecules and uses therefor
‌
US Patent 7638122 Stat3 antagonists and their use as vaccines against cancer
‌
US Patent 7638270 Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
‌
US Patent 7638273 Generation and use of vasculogenic tumors and products derived from same
‌
US Patent 7642044 Trimerising module
‌
US Patent 7642048 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
‌
US Patent 7651685 Use of microchimeric cells in the treatment of malignancy
‌
US Patent 7655458 Nucleic acid molecules encoding endostatin protein and peptide fragments thereof
‌
US Patent 7666607 TRAF family proteins
‌
US Patent 7666609 Method and composition for diagnosis of melanocytic lesions
‌
US Patent 7674456 Breast cancer cell lines and uses thereof
‌
US Patent 7687605 Humanized anti-beta7 antagonists and uses therefor
‌
US Patent 7695716 Methods of treating neoplastic, autoimmune and inflammatory diseases
‌
US Patent 7704943 Transglutaminase for inhibiting angiogenesis
‌
US Patent 7709002 Mutated
‌
US Patent 7709189 Methods for identifying or diagnosing carcinoma cells with metastatic potential based on the measurement of lymphoid genes or their products in carcinoma cells
‌
US Patent 7713526 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
‌
US Patent 7718600 IAP binding compounds
‌
US Patent 7731950 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
‌
US Patent 7732148 Annexin A3 for prostate cancer diagnosis
‌
US Patent 7741023 Method for predicting immune response to neoplastic disease based on mRNA expression profile in neoplastic cells and stimulated leukocytes
‌
US Patent 7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
‌
US Patent 7741447 Antibody against tumor specific antigen as target
‌
US Patent 7744871 Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity
‌
US Patent 7745159 Methods and compositions for diagnosing carcinomas
‌
US Patent 7749486 Tumor models employing green fluorescent protein
‌
US Patent 7750121 Antibody to telomerase reverse transcriptive
‌
US Patent 7754211 Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
‌
US Patent 7754450 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
‌
US Patent 7763243 In situ immunization
‌
US Patent 7767208 Noninvasive vascular therapy
‌
US Patent 7771726 Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
‌
US Patent 7776311 D-amino acid peptides
‌
US Patent 7776324 Cancer vaccine
‌
US Patent 7790152 Enhancer for antibody to lymphocytic tumors
‌
US Patent 7803408 Method of treating endothelial injury
‌
US Patent 7807186 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
‌
US Patent 7807383 Diagnosing and treating hormone resistant cancers
‌
US Patent 7807782 Method for linking molecular substances
‌
US Patent 7824687 Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
‌
US Patent 7829064 Anti-CD74 immunoconjugates and methods
‌
US Patent 7833698 Method for determining the response to cancer therapy
‌
US Patent 7837990 In vivo expanded NKT cells and methods of use thereof
‌
US Patent 7838495 Compositions and methods of use of EPB1, and ErbB3 binding protein
‌
US Patent 7842458 Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
‌
US Patent 7851213 Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
‌
US Patent 7854934 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
‌
US Patent 7871630 Therapeutic modulation of the tumor inflammatory response
‌
US Patent 7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
‌
US Patent 7883841 Methods and kits for testing the efficacy of therapeutic compounds and other therapies in a three-dimensional matrix with respect to tumorous cells and tissue
‌
US Patent 7888320 Composition for treating cancer adapted for intra-tumoral administration and uses thereof
‌
US Patent 7892530 Treatment of tumor metastases and cancer
‌
US Patent 7893023 Prodrugs activated by plasmin and their use in cancer chemotherapy
‌
US Patent 7893026 Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibitor of NF kappab)
‌
US Patent 7897139 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease
‌
US Patent 7897147 Treatment of premenstrual disorders
‌
US Patent 7919314 Process for the production of monoclonal antibodies
‌
US Patent 7923460 None
‌
US Patent 7927612 Combinations and methods for treating neoplasms
‌
US Patent 7939293 Method for producing carboxy-terminal-amidified peptides
‌
US Patent 7947463 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
‌
US Patent 7951356 Tissue factor compositions and kits for coagulation and tumor treatment
‌
US Patent 7951365 Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with specific cancer types
‌
US Patent 7951405 Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor
‌
US Patent 7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
‌
US Patent 7968308 Isolating human antibodies
‌
US Patent 7972769 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
‌
US Patent 7976846 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
‌
US Patent 7977041 Methods and kits for testing the efficacy of therapeutic compounds and other therapies in a three-dimensional matrix with respect to tumorous cells and tissue
‌
US Patent 7993638 Cancer treatment combining lymphodepleting agent with CTLs and cytokines
‌
US Patent 8007991 Three-dimensional physiological matrices for oncological testing, and methods for their production and use
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7993638 Cancer treatment combining lymphodepleting agent with CTLs and cytokines
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7968308 Isolating human antibodies
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7951356 Tissue factor compositions and kits for coagulation and tumor treatment
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7939293 Method for producing carboxy-terminal-amidified peptides
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7927612 Combinations and methods for treating neoplasms

Find more people like Karen A. Canella

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo